• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射链激酶进行冠状动脉再灌注后的随访与残余心肌梗死动脉狭窄的关系。

Follow-up after coronary arterial reperfusion with intravenous streptokinase in relation to residual myocardial infarct artery narrowings.

作者信息

Schröder R, Vöhringer H, Linderer T, Biamino G, Brüggemann T, Leitner E V

出版信息

Am J Cardiol. 1985 Feb 1;55(4):313-7. doi: 10.1016/0002-9149(85)90367-4.

DOI:10.1016/0002-9149(85)90367-4
PMID:3969865
Abstract

Short- and long-term changes in residual stenosis of the myocardial infarct-related coronary arteries in patients with successful reperfusion by intravenous streptokinase have not been determined until now. In 15 patients the residual diameter stenosis decreased significantly from 62 +/- 9% after 24 hours to 55 +/- 13% in the fourth week (p less than 0.005). Quantitative angiographic analyses in 61 patients with patent infarct-related coronary arteries in the fourth week revealed a mean diameter stenosis of 61 +/- 13%. The patients were followed up 34 +/- 10 months. Sixteen had elective coronary artery bypass surgery or percutaneous transluminal coronary angioplasty (PTCA). Eighteen without coronary artery bypass surgery or PTCA had undergone repeat angiography after 26 +/- 9 months. Twenty-five (41%) have had a residual diameter stenosis greater than 65% in the fourth week. A stenosis greater than 65% was found in: 4 of 5 patients with late reinfarction; 3 of 7 with 1-vessel coronary artery disease and persistent angina, compared with none of 11 with a stenosis less than 65%; 6 of 7, whose silent reocclusion had been found at long-term follow-up compared with 1 of 9 with a residual stenosis less than 65%. In 8 patients with persistent patency of the infarct artery, the stenosis had decreased significantly from 55 +/- 6% to 36 +/- 12% (p less than 0.005). Correspondingly, there was a significant improvement in the infarct-related left ventricular wall motion disorders.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

迄今为止,静脉注射链激酶成功实现再灌注的患者,心肌梗死相关冠状动脉残余狭窄的短期和长期变化尚未明确。15例患者的残余直径狭窄从24小时后的62±9%显著降至第四周的55±13%(p<0.005)。对第四周梗死相关冠状动脉通畅的61例患者进行的定量血管造影分析显示,平均直径狭窄为61±13%。对患者进行了34±10个月的随访。16例患者接受了择期冠状动脉搭桥手术或经皮冠状动脉腔内血管成形术(PTCA)。18例未接受冠状动脉搭桥手术或PTCA的患者在26±9个月后接受了重复血管造影。25例(41%)在第四周时残余直径狭窄大于65%。在以下患者中发现狭窄大于65%:5例晚期再梗死患者中有4例;7例单支冠状动脉疾病且持续心绞痛患者中有3例,而11例狭窄小于65%的患者中无一例;7例长期随访发现无症状再闭塞的患者中有6例,而9例残余狭窄小于65%的患者中有1例。8例梗死动脉持续通畅的患者,狭窄从55±6%显著降至36±12%(p<0.005)。相应地,梗死相关左心室壁运动障碍有显著改善。(摘要截短于250字)

相似文献

1
Follow-up after coronary arterial reperfusion with intravenous streptokinase in relation to residual myocardial infarct artery narrowings.静脉注射链激酶进行冠状动脉再灌注后的随访与残余心肌梗死动脉狭窄的关系。
Am J Cardiol. 1985 Feb 1;55(4):313-7. doi: 10.1016/0002-9149(85)90367-4.
2
Assessment of residual coronary arterial stenosis after thrombolytic therapy during acute myocardial infarction.急性心肌梗死溶栓治疗后残余冠状动脉狭窄的评估。
Am J Cardiol. 1987 Jun 1;59(15):1231-3. doi: 10.1016/0002-9149(87)90895-2.
3
High dose intravenous streptokinase in acute myocardial infarction--short and long term prognosis.急性心肌梗死大剂量静脉注射链激酶——短期和长期预后
Br Heart J. 1986 Mar;55(3):231-9. doi: 10.1136/hrt.55.3.231.
4
Intracoronary streptokinase thrombolytic recanalization and subsequent surgical bypass of remaining atherosclerotic stenosis in acute myocardial infarction: complementary combined approach effecting reduced infarct size, preventing reinfarction, and improving left ventricular function.冠状动脉内链激酶溶栓再通术及随后对急性心肌梗死中残留动脉粥样硬化性狭窄进行外科搭桥术:这种互补联合方法可减小梗死面积、预防再梗死并改善左心室功能。
Am Heart J. 1981 Dec;102(6 Pt 2):1194-201. doi: 10.1016/0002-8703(81)90652-9.
5
Acute myocardial infarction-related coronary artery residual narrowing after intravenous streptokinase: relationship with previous coronary symptoms.静脉注射链激酶后急性心肌梗死相关冠状动脉残余狭窄:与既往冠状动脉症状的关系
Am Heart J. 1989 Nov;118(5 Pt 1):888-92. doi: 10.1016/0002-8703(89)90219-6.
6
Percutaneous transluminal coronary angioplasty in evolving acute myocardial infarction.
Am J Cardiol. 1986 May 1;57(13):1069-74. doi: 10.1016/0002-9149(86)90676-4.
7
Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase.急性心肌梗死期间采用冠状动脉血管成形术和大剂量静脉注射链激酶联合治疗的冠状动脉灌注
Circulation. 1988 Jan;77(1):151-61. doi: 10.1161/01.cir.77.1.151.
8
Changes in ventricular function and coronary stenosis after successful intravenous thrombolysis in acute myocardial infarction.急性心肌梗死成功静脉溶栓后心室功能及冠状动脉狭窄的变化
Cardiology. 1988;75(6):419-30. doi: 10.1159/000174412.
9
Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction.经皮腔内冠状动脉成形术联合或不联合溶栓治疗急性心肌梗死
Am Heart J. 1983 Nov;106(5 Pt 1):965-73. doi: 10.1016/0002-8703(83)90639-7.
10
Emergency coronary artery reperfusion: a choice therapy for evolving myocardial infarction. Results in 339 patients.急诊冠状动脉再灌注:进展性心肌梗死的一种选择性治疗。339例患者的结果。
J Thorac Cardiovasc Surg. 1983 Nov;86(5):679-88.

引用本文的文献

1
Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies.单纯溶栓是急性心肌梗死的最佳治疗方法吗?现状与新策略
Tex Heart Inst J. 1991;18(1):50-61.
2
Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.用茴香酰化纤溶酶原链激酶激活剂复合物治疗急性心肌梗死。
Br Med J (Clin Res Ed). 1986 Sep 27;293(6550):786-9. doi: 10.1136/bmj.293.6550.786.
3
Cardiac ischemia. Part II--Reperfusion and treatment.心脏缺血。第二部分——再灌注与治疗。
West J Med. 1987 Jul;147(1):54-61.
4
Influence of the rt-PA dose (1 mg/kg versus 1.5 mg/kg) and duration of administration on the patency of infarct-related coronary arteries in 81 patients.81例患者中rt-PA剂量(1mg/kg与1.5mg/kg)及给药持续时间对梗死相关冠状动脉通畅情况的影响。
Cardiovasc Drugs Ther. 1992 Aug;6(4):373-7. doi: 10.1007/BF00054184.